Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
Published:April 15, 2021
DOI: https://doi.org/10.1016/S2213-8587(21)00056-5
Recent developments in the management of Cushing's syndrome
Pablo Abellán Galiana
EDITORIAL
DOI: 10.1016/j.endinu.2021.01.002
Pituitary (2021)
We report a case of a pregnant woman with Cushing’s disease (CD) and performed a systematic review of literature on diagnosis, treatment, maternal and fetal outcomes of CD in pregnancy.
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages e1937–e1952,
https://doi.org/10.1210/clinem/dgaa982
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages 1325–1332, https://doi.org/10.1210/clinem/dgab070
Published: 09 February 2021
Context/objective
The aim of this study was to examine the effect of statins and other lipid-lowering agents on the development of Graves orbitopathy (GO) in patients with newly diagnosed Graves disease (GD).
Methods
Ya está disponible el vídeo de la reunión de Primavera SVEYDN en el área privada - enlace drive.
